Why BioAge Labs Inc (NASDAQ: BIOA) Stock Should Not Be Taken For Granted By Investors In 2025

IPW

In the last trading session, 0.21 million shares of the BioAge Labs Inc (NASDAQ:BIOA) were traded. Most recently the company’s share price was $5.14, and it changed around $0.1 or 1.98% from the last close, which brings the market valuation of the company to $184.26M. BIOA currently trades at a discount to its 52-week high of $26.62, offering almost -417.9% off that amount. The share price’s 52-week low was $3.85, which indicates that the current value has risen by an impressive 25.1% since then. We note from BioAge Labs Inc’s average daily trading volume that its 10-day average is 0.42 million shares, with the 3-month average coming to 758.25K.

BioAge Labs Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.67. If we narrow it down even further, the data shows that 1 out of 3 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 2 recommended BIOA as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. BioAge Labs Inc is expected to report earnings per share of -0.66 for the current quarter.

BioAge Labs Inc (NASDAQ:BIOA) trade information

Instantly BIOA has showed a green trend with a performance of 1.98% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 5.19 on recent trading dayincreased the stock’s daily price by 0.96%. The company’s shares are currently down -11.23% year-to-date, but still up 4.05% over the last five days. On the other hand, BioAge Labs Inc (NASDAQ:BIOA) is 24.15% up in the 30-day period. We can see from the shorts that 2.06 million shares have been sold at a short interest cover period of 1.24 day(s).

The consensus price target as assigned by Wall Street analysts is $40, which translates to bulls needing to increase their stock price by 87.15% from its current value. Analyst projections state that BIOA is forecast to be at a low of $7 and a high of $45.

BIOA Dividends

BioAge Labs Inc’s next quarterly earnings report is expected to be released in February.

AB Cap Fd.-AB Small Cap Growth Port and Principal Small Cap Growth Fd I were the top two Mutual Funds as of Nov 30, 2024 . The former held 606.05 shares worth $3.12 million, making up 1.69% of all outstanding shares. On the other hand, Principal Small Cap Growth Fd I held roughly 274.39 shares worth around $1.41 million, which represents about 0.77% of the total shares outstanding.